CONNECT WITH US
HealthTech

HealthTech

EU officials call for 'swift and sustained' action on antimicrobial resistance

Medical Xpress logo

Published on

Add as a preferred source on Google
EU officials call for 'swift and sustained' action on antimicrobial resistance

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

European health officials are calling for urgent action as a series of new reports shows a mixed picture on antibiotic consumption and antimicrobial resistance (AMR).

Among the reports released by the European Centre for Disease Prevention and Control (ECDC) was the annual epidemiologic report on antibiotic consumption in European Union/European Economic Area (EU/EEA) countries, which shows a 5% decline in human antibiotic use compared with the 2019 baseline. There was also a small increase in the proportion of World Health Organization–designated first-line antibiotics being used for common infections—a measure of appropriate antibiotic use.

But the drop in antibiotic consumption is far from the EU's 2030 target of a 20% reduction. And the proportion of first-line antibiotics being consumed (62.5%) is short of the 65% goal by 2030.

The targets were established by EU leaders in 2023 as part of the EU's One Health action plan on AMR, which is estimated to cause at least 35,000 deaths every year on the continent.

"We are still behind with several of the EU's 2030 targets to counter antimicrobial resistance," ECDC Director Pamela Rendi-Wagner, MD, said in a press release.

A report on AMR rates in EU/EEA countries shows that bloodstream infections caused by a major drug-resistant pathogen—methicillin-resistant Staphylococcus aureus—have fallen 19% since 2019. 4% and 72%, respectively, since 2019.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.